Founder, President & CEO
Robert DiCrisci is the President, CEO of NextSource Biotechnology (NSB), a sister company of Amatheon Pharmaceuticals. Mr. DiCrisci has over 15 years of experience in the
healthcare and pharmaceuticals industry as an Operations and Technology Executive. As the President, CEO Mr. DiCrisci is responsible for implementing the company vision and overall
business strategy to advance the company’s mission statement, Corporate Objectives, and to promote revenue growth, and profitability. Additionally, Mr. DiCrisci is responsible for
the high level guidance of all company Sales and Operational direction in line with the Corporate Objectives.
Mr. DiCrisci is the Licensed DEA Registrant for all regulatory afford. He has successfully held Executive Management positions working in both the Public and Private Sector.
His experience includes holding positions as CEO, COO, CIO, Operations Director and Executive IT Director. These positions were held separately for the following businesses
– Medical Staffing Network, Cosabella Inc., Health Coalition, University of Michigan Health Systems, AAA Auto Club Group, HRH Construction, and Sirco Associates.
Prior to holding the above management positions he was a Microsoft Systems Engineer and Programming consultant. Robert also holds the following certifications and licenses:
Project Management Institutes highly regarded Business PMP License as a Project Management Professional. Additionally, early in Mr. DiCrisci’s career he served as an Engineer
and acquired his MCSE CNA & CCNP Designations.
Chris F. Yankana
Chief Financial Officer
Chris Yankana is the Chief Financial Officer of NextSource Biotechnology (NSB). Mr. Yankana has over 20 years of experience in the healthcare and pharmaceutical industry as
CFO, Controller, Auditor and Sales Manager. As the CFO for NextSource, he plays a vital role in developing and implementing the national strategies, financial planning, purchasing
programs. He also serves as an advisor to all department including the Sales/Marketing initiatives. He is responsible for overseeing all fiscal and fiduciary responsibilities for
NextSource Biotechnology and its subsidiaries.
Mr. Yankana is the Resident Certified Designated Representative and is also a Certified Public Accountant (CPA). His experience includes positions as the Controller then Sales Manager for Health Coalition; prior to this he served
as an Accounting Auditor for several large NYC companies.
Executive Vice President
As the Executive Vice President, Mr. Charria brings to the table a wealth of knowledge with over 13 years of Executive management experience in industries such as Healthcare,
Pharmaceuticals, Aerospace, Transportation and Logistics. This has given him the necessary tools to operate as NextSource’s Executive Vice President. Mr. Charria is responsible
for executing the corporate business plans to efficiently optimize the organization. He is also responsible for overseeing the management of short term and long term corporate
goals. Mr. Charria undertakes a strategic role in every aspect of our business development process and reports to directly to the CEO in implementing, executing and delegating
all corporate objectives. He has produced outstanding and innovative results that have allowed him to excel throughout his career.
Carlos Charria – BS, graduated with honors from Embry-Riddle Aeronautical University with a Bachelors of Science in Management of Technical Operations. Carlos has also held Executive
Management positions working in both the Public and Private Sectors for several FORTUNE 500 companies. His experience includes positions as a Senior Sales Manager, Logistics Manager,
Regional Sales Manager, Senior Operations Manager and Executive Director of Business Development for companies such as – FedEx Inc., Enterprise Inc., Medical Staffing Network, LLC,
Amatheon Inc., Apex Aerospace Solutions Inc., and currently NextSource Biotechnology (NSB).
Kevin A. Hahn, DVM, PhD, DACVIM
Chief Scientific Officer, Executive Vice President
Kevin A. Hahn, DVM, PhD, DACVIM (Oncology) is Chief Scientific Officer and Executive Vice President for NextSource Biotechnology (NSB). Dr. Hahn has over 25 years of experience in the
veterinary healthcare, nutrition, and pharmaceutical industry. As CSO he leads the NextSource Biotechnology global new product pre-clinical development and regulatory approval strategy and
serves as a key advisor during the development and implementation of Sales/Marketing initiatives.
Prior to joining NextSource Biotechnology he served as Chief Medical Officer for Hill’s Pet Nutrition, Inc. (Topeka, KS); Senior Partner for Gulf Coast Veterinary Oncology & Diagnostic Imaging
(Houston, TX); and Associate Professor of Medical Oncology, University of Tennessee (Knoxville, TN).
Dr. Hahn is an entrepreneur, scientist, veterinarian, and community supporter. He actively participates in causes that enrich the human-animal bond as well as the human-spiritual bond.
He is recognized internationally in the discipline of veterinary medical oncology, companion animal nutrition, comparative biosciences, and is an active leader in the animal health industry.
Richard C. Dinovitz
Chief Commercial Officer & Executive Vice President
Richard Dinovitz is Chief Commercial Officer (CCO) and Executive Vice President for NextSource Biotechnology (NSB).
Richard has over 35 years of experience in the vaccine, biological, biotech, and pharmaceutical industries. As CCO
he is responsible for the NextSource Biotechnology global strategy and the development of the organization to drive
business growth and market share.
Richard is an accomplished sales and marketing officer-level executive with wide-ranging experience in complex technical
markets. He is a creative thinker equally comfortable in strategic planning, business development product launches,
commercial team management and leadership. He is a serial entrepreneur experienced in company startups, venture funding,
co-promotions, mergers and acquisitions. Richard is a business executive who understands the need to exceed expectations
as well as to over achieve aggressive targets.
Richard spent over 30 years in positions of increasing responsibility with Pfizer where he consistently delivered strong
financial growth through building high performing teams, identifying/capitalizing on business and product specification
opportunities, expanding distribution channels/networks, launching new products, and developing innovative marketing
strategies. Additionally, he gained considerable expertise in government negotiation, commercial operations, strategic
alliance management, and contracting.
As Vice President, Business Development at a start-up company, Nuron Biotech, Richard impressively led the company's effort
to acquire five pharmaceutical and vaccine products within a two year period. He successfully worked with investors to secure
sufficient capital to ensure appropriate funding of the company.
Richard has founded two companies, Vaccines Business Logistics and RCDVaccine, LLC where he has served as President and COO.
These companies were launched to help increase patient access to important vaccines, enhance immunization rates, and to provide
a brokerage of products and services for companies within the vaccines industry. These companies serve to offer exemplary
consulting services to vaccine providers, manufacturers, and suppliers to meet both commercial and philanthropic goals.
Richard received his B.S degree from the University of Pittsburgh. Richard remains active in various Trade Organizations and
Director of Strategic Planning & Market Access
Mr. Armand brings over 30 years of executive experience in the pharmaceutical industry. He has extensive knowledge and understanding of the industry across numerous therapeutic areas including
Dermatology, Hematology/Oncology, specifically in; Lymphomas/Leukemia’s, Genitourinary, Gynecological, Colorectal Head and Neck and Breast Cancers. As Director of Strategic Planning and Market
Access he is responsible for identifying and implementing programs which support our portfolio of products by all stakeholders. He also works across platforms, both internal and external,
to ensure flawless execution of our Access Strategy. Mr. Armand was instrumental during the formative phase of the company by helping to develop the structural foundation of NextSource Biotechnology.
Raul Armand graduated from Florida State University with a Bachelor of Business Administration in Marketing and Communications. During his stellar career at Bristol-Myers Squibb in Direct
Marketing and Training he won numerous awards and was inducted into “Grand Master.” Throughout the years he served as a mentor to many colleagues and as a consultant to senior management
and brand agencies. Raul lives in Miami, is married and has two daughters, he volunteers his time and talents with a local Non-Profit helping orphaned and abandoned children.